Similar Posts
IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency
8 May 2012 This statement is intended to provide a summary of IPOPI’s position with regards to the importance of ensuring access for patients living with a primary immunodeficiency (PID) to the best suited immunoglobulin (IG) replacement therapy, as selected and prescribed by their physician. IPOPI is concerned by recent developments in several countries that…
IPOPI CONGRESS REPORT – BUDAPEST 2015
Find out about what transpired at the 2015 International Primary Immunodeficiency Congress with this detailed overview of the event.